Peter A. Thompson bought $10.0M of Edgewise Therapeutics (EWTX)
Executed Apr 3 2025, disclosed Apr 4 2025, 1 day later.
Over the 21 trading sessions from the disclosed entry session (Apr 4 2025), the stock returned +30.5% (delay-adjusted); from the execution session (Apr 3 2025), +13.5%. Derived: entry at the session's open, exit at the close 20 sessions later.
Peter A. Thompson (Director) filed 9 Form 4 reports in the trailing twelve months (1 purchase, 8 sales), most often in Sionna Therapeutics, Inc. (SION). The largest single filing was $22.9M of SION (510,583 sh across 3 lots, as filed), executed Apr 14. The median gap between execution and disclosure was 2 days.
Healthcare · Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle dis…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→